Skip to Main Content

Paper Details

Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.
Eur Heart J
22
2023
HF, Participant, Sacubitril, cardiovascular, end-stage renal disease, heart failure, participant, participants, patients, renal death, sacubitril, valsartan
Author NameAffiliation
Adrian F HernandezDuke Clinical Research Institute
David A MorrowBrigham and Women's Hospital, Harvard Medical School
David A MorrowBrigham and Women's Hospital, Harvard Medical School
Eric J VelazquezYale School of Medicine
Eric J VelazquezYale School of Medicine
Akshay S DesaiBrigham and Women's Hospital, Harvard Medical School
Eugene BraunwaldBrigham and Women's Hospital, Harvard Medical School
  • 1 - 7

Datasets

Release 1.2